Pacaña, Emmalou S.

HRN: 14-63-96  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2022
AMPICILLIN 1GM (VIAL)
05/29/2022
05/30/2022
IV
2g
Q6
Prom X16hrs
Waiting Final Action 
05/30/2022
CEFUROXIME 500MG (TAB)
05/30/2022
06/06/2022
PO
500mg
Q12
UTI; PROM
Waiting Final Action 
05/30/2022
CEFUROXIME 500MG (TAB)
05/30/2022
06/06/2022
ORAL
500mg
Q12
PROM, UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: